Browse > Article

Commonly Used Surfactant, Tween 80, Improves Absorption of P-Glycoprotein Substrate, Digoxin, in Rats  

Zhang, Hongjian (Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Pharmaceutical Research Institute)
Yao, Ming (Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Pharmaceutical Research Institute)
Morrison, Richard-A. (Schering-Plough Research Institute)
Chong, Sae-Ho (Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Pharmaceutical Research Institute)
Publication Information
Archives of Pharmacal Research / v.26, no.9, 2003 , pp. 768-772 More about this Journal
Abstract
Tween 80 (Polysorbate 80) is a hydrophilic nonionic surfactant commonly used as an ingredient in dosing vehicles for pre-clinical in vivo studies (e.g., pharmacokinetic studies, etc.). Tween 80 increased apical to basolateral permeability of digoxin in Caco-2 cells suggesting that Tween 80 is an in vitro inhibitor of P-gp. The overall objective of the present study was to investigate whether an inhibition of P-gp by Tween 80 can potentially influence in vivo absorption of P-gp substrates by evaluating the effect of Tween 80 on the disposition of digoxin (a model P-gp substrate with minimum metabolism) after oral administration in rats. Rats were dosed orally with digoxin (0.2 mg/kg) formulated in ethanol (40%, v/v) and saline mixture with and without Tween 80 (1 or 10%, v/v). Digoxin oral AUC increased 30 and 61% when dosed in 1 % and 10% Tween 80, respectively, compared to control (P<0.05). To further examine whether the increase in digoxin AUC after oral administration of Tween 80 is due, in part, to a systemic inhibition of digoxin excretion in addition to an inhibition of P-gp in the GI tract, a separate group of rats received digoxin intravenously (0.2 mg/kg) and Tween 80 (10% v/v) orally. No significant changes in digoxin IV AUC was noted when Tween 80 was administered orally. In conclusion, Tween 80 significantly increased digoxin AUC and Cmax after oral administration, and the increased AUC is likely to be due to an inhibition of P-gp in the gut (i.e., improved absorption). Therefore, Tween 80 is likely to improve systemic exposure of P-gp substrates after oral administration. Comparing AUC after oral administration with and without Tween 80 may be a viable strategy in evaluating whether oral absorption of P-gp substrates is potentially limited by P-gp in the gut.
Keywords
P-glycoprotein (P-gp); Digoxin; Tween 80; Pharmacokinetics;
Citations & Related Records

Times Cited By Web Of Science : 32  (Related Records In Web of Science)
Times Cited By SCOPUS : 32
연도 인용수 순위
1 Cornaire, G., Woodley, J. F., Saivin, S., Legendre, J.Y., Decourt, S., Cloarec, A., and Houin, G., Effect of polyoxyl 35 castor oil and Polysorbate 80 on the intestinal absorption of digoxin in vitro. Arzneimittel-forschung., 50, 576-579 (2000)   PUBMED
2 Hedman, A., Angelin, B., Arvidsson, A., Dahlqvist, R., and Nilsson, B.. Interactions in the renal and biliary elimination of digoxin: stereoselective difference between quinine and quinidine. Clin. Pharmacol. Ther., 47, 20-26 (1990)   DOI   PUBMED   ScienceOn
3 Hinderling, P. H. and Hartmann, D., Pharmacokinetics of digoxin and main metabolites/ derivatives in healthy humans. Ther. Drug Monit., 13, 381-401 (1991)   DOI   PUBMED   ScienceOn
4 Hugger, E. D., Novak, B. L., Burton, P. S., Audus, K. L., and Borchardt, R. T., A comparison of commonly used polyehtoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro. J. Pharm. Sci., 91, 1991-2002 (2002)   DOI   ScienceOn
5 Litman, T., Druley, T. E., Stein, W. D., and Bates, S. E., From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell. Mol. Life Sci. 58, 931-959 (2001)   DOI   ScienceOn
6 Malingre, M M., Schellens, J. H., Van Tellingen, O., Ouwehand, M., Bardelmeijer, H. A., Rosing, H., Koopman, F. J., Schot, M. E., Ten Bokkel Huinink, W. W., and Beijnen, J. H., The cosolvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients. Br. J. Cancer, 85, 1472-1477 (2001)   DOI   ScienceOn
7 Stephens, R. H., O'Neill, C. A., Warhurst, A., Carlson, G. L., Rowland, M., and Warhurst, G., Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia. J. Pharmacol. Exp. Ther., 296, 584-591 (2001)   PUBMED
8 Verschraagen, M., Koks, C. H., Schellens, J. H., and Beijnen, J. H., P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil. Pharmacol. Res., 40, 301-306 (1999)   DOI   ScienceOn
9 Yao, M., Zhang, H., Chong, S., Zhu, M., and Morrison, R. A., A rapid and sensitive LC/MS/MS assay for quantitative determination of digoxin in rat plasma. J. Pharmaceu. Biomed. Anal., 32, 1189-1197 (2003)   DOI   ScienceOn
10 Silverman, J. A., Multidrug-resistance transporters. Pharm. Biotechnol., 12, 353-86 (1999)   PUBMED
11 Tanigawara, Y., Role of P-glycoprotein in drug disposition. Ther. Drug Monit., 22, 137-140 (2000)   DOI   PUBMED   ScienceOn
12 Salphati, L. and Benet, L. Z., Metabolism of digoxin and digoxigenin digitoxosides in rat liver microsomes: involvement of cytochrome P4503A. Xenobiotica, 29, 171-85 (1999)   DOI   PUBMED   ScienceOn
13 Troutman, M. D., Luo, G., Gan, L. S., and Thakker, D. R., The role of P-glycoprotein in drug disposition: significance to drug development. In Rodrigues, A. D. (ed.). Drug-drug interactions. Marcel Dekker, New York. pp. 295-357 (2001)
14 Fromm, M. F., Kim, R. B., Stein, C. M., Wilkinson, G. R., and Roden, D. M., Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine. Circulation, 99, 552-557 (1999)   DOI   PUBMED   ScienceOn
15 Gottesman, M. M. and Pastan, I., Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 62, 385-427 (1993)   DOI   ScienceOn
16 Nerurkar, M. M., Ho, N. F., Burton, P. S., Vidmar, T. J., and Borchardt, R. T., Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport a model peptide in Caco-2 cells. J. Pharm. Sci., 86, 813-821 (1997)   DOI   ScienceOn
17 Salphati, L. and Benet, L. Z., Effects of ketoconazole on digoxin absorption and disposition in rat. Pharmacology, 56, 308-313 (1998)   DOI   ScienceOn
18 Knutsen, T., Mickley, L. A., Ried, T., Green, E. D., du Manoir, S., Schrock, E., Macville, M., Ning, Y., Robey, R., Polymeropoulos, M., Torres, R., and Fojo, T., Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein, in drug-selected cell lines and patients with drug refractory ALL. Genes Chromosomes Cancer, 23, 44-54 (1998)   DOI   ScienceOn
19 van Zuylen, L., Verweij, J., and Sparreboom, A., Role of formulation vehicles in taxane pharmacology. Invest. New Drugs, 19,125-141 (2001)   DOI   ScienceOn
20 Song, S., Suzuki, H., Kawai, R., and Sugiyama, Y., Effect of PSC 833, a P-glycoprotein modulator, on the disposition of vincristine and digoxin in rats. Drug Metab. Disp., 27, 689-694 (1999)
21 Iisalo, E., Clinical pharmacokinetics of digoxin. Clin. Pharmacokinet., 2, 1-16 (1977)   DOI   PUBMED   ScienceOn
22 Yamazaki, M., Neway, W. E., Ohe, T., Chen, I., Rowe, J. F., Hochman, J. H., Chiba, M., and Lin, J. H., In vitro substrate identification studies for p-glycoprotein-mediated transport: species difference and predictability of in vivo results. J. Pharmacol. Exp. Ther., 296, 723-735 (2001)   PUBMED
23 Batrakova, E. V., Han, H. Y., Alakhov, V. Y., Miller, D. W., and Kabanov, A. V., Effects of pluronic block copolymers on drug absorption in Caco-2 cell monolayers. Pharm. Res., 15, 850-855 (1998)   DOI   ScienceOn
24 Borst, P., Evers, R., Kool, M., and Wijnholds, J., The multidrug resistance protein family. Biophys. Acta, 1461, 347-357 (1999)   DOI   ScienceOn